LDS/Medical Tests/Alanine Aminotransferase (ALT)

Alanine Aminotransferase (ALT)

Alanine aminotransferase (ALT) is an intracellular enzyme that is present primarily in the liver hepatocytes. The most basic function for the enzyme is to catalyze transfer of an amino group from alanine to alpha-ketoglutarate. Due to the fact that hepatic tissue is the major source of ALT activity, elevations can be used to diagnose liver disease. Elevated ALT levels can be found in many diseases involving the liver such as hepatitis, cirrhosis, obstructive jaundice, carcinoma of the liver, and chronic alcoholism. To a lesser extent ALT can be found in skeletal muscle, kidney, heart, pancreas, lungs, spleen, and erythrocytes. Aspartate aminotransferase (AST) also increases when disease affects liver tissue, but ALT activity is more specific to hepatic tissue and remains elevated longer than the AST enzyme levels.

The rise in AST and ALT are often parallel to each other. Because the pattern of these two enzymes’ change is similar, usually only one is monitored to follow the course of disease, usually ALT in liver disease. It should be noted that in vitro most enzymes are not directly measured. It is the substrate they act upon that is measured, and extremely high enzyme activity can sometimes give a false low result due to the hook effect. Further investigation should be utilized if this is suspected.

  • To evaluate liver function and diagnosis of liver disorders including infectious hepatitis, alcoholic hepatitis, nonalcoholic steatohepatitis, liver cancer, hepatotoxicity, drug induced hepatitis
  • Monitoring enzyme levels in myocardial infarction
  • Assessment or evaluation of liver function in patients with a history of liver disease
  • Monitoring treatment

Increased in:

  • Acute viral hepatitis, alcoholic hepatitis and cirrhosis, liver cancers
  • Chronic hepatitis
  • Myocardial infarction, right heart failure and left heart failure(usually less than AST)
  • Ischemia or hypoxia, injury to liver ("shock liver")
  • Extensive trauma
  • Biliary tract obstruction (cholangitis, choledocholithiasis)
  • Drugs that cause cholestasis or hepatotoxicity
  • Fatty liver
  • Myocarditis
  • Myositis
  • Severe pancreatitis
  • Muscular dystrophy
  • Filariasis
  • Severe burns
  • Hemochromatosis
  • Wilson's disease
  • Preeclampsia
  • Obesity

Decreased in:

  • Pyridoxine (vitamin B6) deficiency

5-30 U/L (0.09-0.51 µmol/L)

 

 

Kinetic, enzymatic. 

Serum (SST).

Stability

  • Ambient: 72 hours
  • Refrigerated: 5 days
  • Frozen: Unacceptable
Liver Function Panel (Albumin; ALP, AST, Bilirubin Direct, Protein Total, and Bilirubin Total), Gamma Glutamyl Transferase, 5'Nucleotidase, Amylase, Lipase, LDH, Creatine Kinase, Viral hepatitis studies including A, B and C, Ceruloplasmin, Serum Iron, Iron binding capacity, Alpha-1-antitrypsin, ANA, anti-smooth muscle antibody, anti-mitochondrial antibody, ANCA (p- and c-), anti-Sm antibody.
Same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Med. 2002 Sep-Oct;2(5):406-9. [PMID: 12448585]
  • Clin Gastroenterol Hepatol. 2005;3:852. [PMID: 16234021]
  • CMAJ. 2005;172:367. [PMID: 15684121]
  • Am J Gastroenterol. 2006;101:76. [PMID: 16405534]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757